Ovarian hyperstimulation syndrome and its effect on renal function in a renal transplant patient undergoing IVF treatment

Human Reproduction

Volumn 15, Issue 6, 2000, Pages 1275-1277

  Khalaf, Y ^a   Elkington, N ^a   Anderson, H ^a   Taylor, A ^a   Braude, P ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Embryo cryopreservation; IVF; Ovarian hyperstimulation syndrome; Renal transplant

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ANALGESIC AGENT; ANTIBIOTIC AGENT; AZATHIOPRINE; BUSERELIN; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; COTRIMOXAZOLE; CYCLOSPORIN; GOSERELIN; METOPROLOL; RECOMBINANT FOLLITROPIN;

ABDOMINAL DISTENSION; ADULT; ARTICLE; CASE REPORT; EMBRYO TRANSFER; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; NAUSEA; OBSTRUCTION; OVARY DISEASE; PAIN; PELVIS PAIN SYNDROME; URINARY TRACT INFECTION; VOMITING;

EID: 0034073021     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.6.1275     Document Type: Article

References (14)

1. Aboulghar, M.A., Mansour, R.T., Serour, G.I. et al. (1996) Recombinant follicle-stimulating hormone in the treatment of patients with history of severe ovarian hyperstimulation syndrome. Fertil. Steril., 66, 757-760.
2. Amso, N.N., Ahuja, K.K., Morris, N. and Shaw, R.W. (1990) The management of predicted ovarian hyperstimulation involving gonadotropin-releasing hormone analog with elective cryopreservation of all pre-embryos. Fertil. Steril., 53, 1087-1090.
3. Asch, R.H., Ivery, G., Goldsman, M. et al. (1993) The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Hum. Reprod., 8, 1015-1020.
4. Ben-Rafael, Z., Levy, T. and Schoemaker, J. (1995) Pharmacokinetics of follicle-stimulating hormone: clinical significance. Fertil. Steril., 63, 689-700.
5. Brinsden, P., Wada, I., Tan, S. et al. (1995) Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Hum. Reprod., 10, 767-772.
6. Chen, C.D., Wu, M.Y., Chao, K.H. et al. (1997) Serum estradiol level and oocyte number in predicting severe ovarian hyperstimulation syndrome. J. Formos. Med. Assoc., 96, 829-834.
7. Daya, S. and Gunby, J. (1999) Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction. Hum. Reprod., 14, 2207-2215.
8. Khalaf, Y., Adeaga, S., Elkington, N. et al. (1998) Prediction of ovarian hyperstimulation syndrome in IVF cycles. Fertil. Steril., 70 (Suppl. 1), (abstract book), pp. S440.
9. Lockwood, G., Ledger, W. and Barlow, D. (1995) Successful pregnancy outcome in a renal transplant patient following in vitro fertilisation. Hum. Reprod., 10, 1528-1530.
10. Morris, R.S., Paulson, R.J., Sauer, M.V. and Lobo, R.A. (1995) Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome. Hum. Reprod., 10, 811-814.
11. Rizk, B. and Smitz, J. (1992) Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures. Hum. Reprod., 7, 320-327.
12. Navot, D., Bergh, P.A. and Laufer, N. (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil. Steril., 58, 249-261.
13. Sher, G., Zouves, C., Feinman, M. and Maassarani, G. (1995) 'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum. Reprod., 10, 3107-3109.
14. Schenker, J.G. (1993) Prevention and treatment of ovarian hyperstimulation. Hum. Reprod., 8, 653-659.